Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mitie appoints Chris Rogers as its next chair

(Sharecast News) - Mitie Group announced the appointment of Christopher Rogers as its chair-elect on Wednesday, to succeed Derek Mapp as chair following the company's annual general meeting on 22 July, when Mapp would step down after eight years on the board. The FTSE 250 facilities management company said Rogers would bring extensive boardroom experience, currently serving as chair of Wickes Group and senior independent director at Kerry Group.

He was previously a non-executive director at Vivo Energy and Travis Perkins.

"I am delighted to be joining the board of Mitie," Chris Rogers commented.

"Mitie has a highly experienced management team and I am looking forward to working with them and the board to grow and develop the business further and to continue to deliver value for all Mitie's stakeholders."

Mitie noted that during his executive career, Rogers had been an executive director at Whitbread from 2005 to 2016, where he served as chief financial officer for seven years before becoming global managing director of Costa Coffee.

His earlier roles included senior finance and commercial positions at Kingfisher and Woolworths Group.

"Derek Mapp has been an inspirational chairman during Mitie's evolution and its emergence as the UK's largest technology-led facilities transformation business," said chief executive officer Phil Bentley.

"I'd like to thank him for his wise counsel, strategic judgement and his 'eye' for creating value - he will be missed.

"Mitie is now a world class company and I very much look forward to working closely with Chris, as we take the business forward and enter the second year of our facilities transformation three-year plan."

At 0915 GMT, shares in Mitie Group were down 0.14% at 112.44p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.